HHS Seeks Public Input on Wireless Radiation; Cancer News Roundup
Health and Human Services Secretary Robert F. Kennedy Jr. has requested public comments on potential health effects of electromagnetic fields and wireless radiation. Other cancer-related developments include an expression of concern about a Nobel laureate's research, a lawsuit against L'Oréal over hair relaxers, and FDA approvals for new imaging and treatment agents.
The FDA cleared two new agents: a lutetium-based radioligand for gastroenteropancreatic neuroendocrine tumors and a FET-PET tracer for glioma. Both expand options for imaging and treatment.
Additional findings showed exercise linked to better survival across roughly 8,500 patients, mind-body practices easing symptoms in 500 patients, a rare germline mutation raising lung cancer risk up to 25-fold in Appalachia, and an anti-seizure medication slowing an aggressive childhood brain cancer in preclinical models.
This news roundup spans regulatory, legal, and clinical developments. The wireless radiation inquiry could shape future public health guidance affecting billions of device users, though scientific consensus remains unsettled. Lawsuits over hair relaxers and biosimilar patents may influence corporate accountability and drug market competition. New FDA approvals could expand treatment and diagnostic options for specific cancers. Evidence linking exercise and mind-body interventions to better outcomes may encourage broader integration of lifestyle approaches into standard oncology care.